A veteran of large pharmaceutical companies and payers, Martin brings years of experience to position Vitafluence for partnerships and collaborations with these key stakeholders.
– Dr Peter O. Owotoki, CEO Vitafluence.ai
KRONBERG, GERMANY, September 27, 2021 /EINPresswire.com/ – Vitafluence.ai is proud to announce and welcome Martin Dober, as a team advisor to scale up the development and commercialization of digital biomarkers for diagnostics and surveillance of neurological conditions. As a veteran of large pharmaceutical companies and major payers, Martin brings years of experience to position Vitafluence for partnerships and collaborations with these important stakeholders, a key pillar of the next phase of Vitafluence.ai’s development.
A former executive of a pharmaceutical company – Roche and Payor – Zurich Insurance Company as well as other leading European companies, Martin brings unparalleled industry experience and an entrepreneurial spirit to propel Vitafluence.ai as he drives forward its digital and therapeutic biomarkers, including clinical validation and marketing. Martin brings unique insights into the purchasing practices of these global companies that will be invaluable in guiding Vitafluence as it navigates partnerships and collaborations to expand adoption of its digital biomarkers and therapeutics.
A great human leader, Martin will also support the leadership of Vitafluence to create a world-class culture that optimizes performance with the holistic well-being of the total person in the workplace.
Martin is married with two daughters and loves exploring the majestic mountains of Switzerland with his family and enjoying fine dining with his wife. His morning swims in Lake Zurich are a regular source of energy and inspiration.
“We are very happy to have Martin on board for this very impactful trip. His vast experience, extensive relationships, in-depth knowledge of the purchasing practices of some of our key stakeholders and excellent human leadership are a great addition to our team that will accelerate our traction and impact as a force for the good of transforming the neuro health journey for people around the world ”Dr Peter O. Owotoki, co-founder and CEO of Vitafluence.ai.
And in Martin’s words: “I am convinced that the power of digital technology with data analysis, artificial intelligence, automation and remote monitoring will bring more innovation and boost efficiency in the health care sector. Peter, Wamuyu, and the Vitafluence team have led compassionate AI solutions that address mental health challenges and create opportunity through cutting-edge digital technology. I am super motivated, honored to be part of the Vitafluence journey and to have an impact on the neurohealth community.
About Vitafluence.ai GmbH
Vitafluence.ai transforms the neuro-health journey.
As a data and artificial intelligence (AI) start-up with a mission to connect the dots to create empathic and responsible AI-based health solutions that improve human quality of life and close the gap in human life. access to health care. The company focuses on conditions considered to have gender, ethnicity and age biases, such as Autism Spectrum Disorder (ASD).
Dr Peter Owotoki
Westerbachstr. 23, D-61476 Kronberg i. Ts.
+49 6173 7838280
write us here
Visit us on social networks: